Every SEC Form 3/4/5 on record for this filer (CIK 1369091) — 7 issuers, 40 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| NVCR | NovoCure Ltd | Director | 2015-10-01 → 2026-06-05 | 18 | −$9M |
| NUVB | Nuvation Bio Inc. | Director | 2021-02-12 → 2026-05-26 | 9 | — |
| MKC | MCCORMICK & CO INC | Director | 2017-05-25 → 2026-02-18 | 19 | — |
| XENT | Intersect ENT, Inc. | Director · lapsed | 2016-06-06 → 2020-06-08 | 7 | — |
| AXON | AXON ENTERPRISE, INC. | Director · lapsed | 2017-04-11 → 2017-05-16 | 3 | $999,992 |
| WWAV | WHITEWAVE FOODS Co | Director · lapsed | 2016-01-05 → 2017-04-13 | 6 | — |
| MDVN | MEDIVATION, INC. | Director · lapsed | 2015-12-16 → 2016-09-30 | 3 | $610,350 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| NVCR | 2026-06-02 | Sell | 2,945 | $15.77 | $46,443 | 197,657 |
| NVCR | 2025-06-03 | Sell | 999 | $17.35 | $17,333 | 167,887 |
| NVCR | 2024-06-04 | Sell | 964 | $23.89 | $23,030 | 164,833 |
4 of 7 issuers are covered and open a security page; the rest are on file here only.
